IGNACIO
MARÍN JIMÉNEZ
Profesor asociado de Ciencias de la Salud
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Gregorio Marañón (50)
2023
-
Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice
Frontiers in Microbiology, Vol. 13
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease
Biomedicine and Pharmacotherapy, Vol. 159
2022
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Frontiers in Medicine, Vol. 9
-
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study
Gastroenterologia y Hepatologia, Vol. 45, Núm. 3, pp. 165-176
-
Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stress
Scientific Reports, Vol. 12, Núm. 1
-
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study
Digestive and Liver Disease, Vol. 54, Núm. 1, pp. 76-83
2021
-
Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits
Journal of Pharmaceutical and Biomedical Analysis, Vol. 198
-
Conocimientos, percepciones, actitud, barreras y facilitadores del uso de biosimilares entre médicos y farmacéuticos de hospital: Una encuesta española
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 5, pp. 240-246
-
Corrigendum to “Recomendaciones del Grupo Español de Trabajo en enfermedad de Crohn y colitis ulcerosa (GETECCU) sobre la reservoritis en la colitis ulcerosa. Parte 2: Tratamiento” [Gastroenterología y Hepatología 2020;43(10):649-658](S0210570520301606)(10.1016/j.gastrohep.2020.04.004)
Gastroenterologia y Hepatologia
-
Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing
European journal of gastroenterology & hepatology, Vol. 33, Núm. 1S Suppl 1, pp. e796-e802
2020
-
COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)
Gastroenterologia y Hepatologia, Vol. 43, Núm. 7, pp. 408-413
-
Differential expression of SMAD genes and S1PR1 on circulating cd4+ t cells in multiple sclerosis and crohn’s disease
International Journal of Molecular Sciences, Vol. 21, Núm. 2
-
History of inflammatory bowel disease on eleven infographics
Gastroenterologia y Hepatologia
-
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: The VERNE study
BMJ Open Gastroenterology, Vol. 7, Núm. 1
-
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment
Gastroenterologia y Hepatologia, Vol. 43, Núm. 10, pp. 649-658
-
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis
Gastroenterologia y Hepatologia, Vol. 43, Núm. 2, pp. 97-105
-
Year 1932: The first detailed description of regional enteritis
Gastroenterologia y Hepatologia, Vol. 43, Núm. 7, pp. 363-364
-
Year 1938: First recognition of the perianal disease as part of Crohn's disease
Gastroenterologia y Hepatologia, Vol. 43, Núm. 7, pp. 365-366